Charles M Baum Poseida Therapeutics, Inc. (PSTX) insider trading activity

PSTX Quotes by TradingView

Charles M Baum is of Poseida Therapeutics, Inc.. Currently has a direct ownership of 0 shares of PSTX, which is worth approximately $0. The most recent transaction as insider was on Jan 08, 2025, when has been sold 78,600 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
100.0% 3M change
100.0% 12M change
Total Value Held $0

CHARLES M BAUM Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 08 2025
SELL
Disposition due to a tender of shares in a change of control transaction
-
78,600 Reduced 100.0%
0 Common Stock
Jun 17 2024
BUY
Grant, award, or other acquisition
-
19,650 Added 20.0%
78,600 Common Stock
Jun 15 2023
BUY
Grant, award, or other acquisition
-
19,650 Added 25.0%
58,950 Common Stock
Jun 16 2022
BUY
Grant, award, or other acquisition
-
39,300 Added 50.0%
39,300 Common Stock

Also insider at

IMMU
IMMUNOMEDICS INC
Director
MRTX
Mirati Therapeutics, Inc. Healthcare
Founder, President, and CEO
PMVP
PMV Pharmaceuticals, Inc. Healthcare
ACRV
Acrivon Therapeutics, Inc.
CMB

Charles M Baum

San Diego, CA

Track Institutional and Insider Activities on PSTX

Follow Poseida Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PSTX shares.

Notify only if

Insider Trading

Get notified when an Poseida Therapeutics, Inc. insider buys or sells PSTX shares.

Notify only if

News

Receive news related to Poseida Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on PSTX